Different mechanisms for hormonal resistance include loss of ER in the cancer cells, ER mutation, HER2 mutation, epigenetic alteration, and most importantly Phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) mTOR signaling pathway activation [43]. Here, ERBB2 is linked to cancer.